At 18.3% CAGR, Europe Handheld Ultrasound Scanners Market is Projected to be Worth US$ 310.16 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the Europe handheld ultrasound scanners market was valued at US$ 80.91 million in 2023 and is expected to reach US$ 310.16 million by 2031, registering a CAGR of 18.3% from 2023 to 2031. Increased adoption of handheld point-of-care ultrasound (POCUS) devices and real-time delivery and rise in demand for image-based diagnostic systems and real-time delivery are among the critical factors attributed to drive the Europe handheld ultrasound scanners market growth.

Point of care ultrasound (POCUS) is a flexible diagnostic tool that enables physicians to incorporate ultrasound imaging directly into patient evaluation and intervention. This instant access to medical imaging can speed up the process of diagnosis and treatment, which is especially helpful in emergencies. Therefore, POCUS has the potential to significantly improve patient outcomes in addition to increasing the efficacy of medical treatment. As POCUS makes better use of time and resources, it also has the potential to reduce healthcare expenditures. The use of point-of-care ultrasound (POCUS) devices is growing quickly among medical professionals, owing to their portability, the speed with which findings can be obtained to inform clinical judgment, and the fact that patients are not exposed to radiation. Many physicians now have better access to ultrasound owing to the recent proliferation of handheld ultrasound technologies. Physicians in emergency medicine, critical care, cardiology, and other specialties are increasingly utilizing POCUS for real-time diagnostic imaging, allowing for faster decision-making and improved patient outcomes. This shift toward decentralized ultrasound has led to a significant increase in demand for handheld scanners. Advancements in technology have dramatically improved the image quality and functionality of handheld POCUS devices. Modern scanners offer high-resolution imaging, advanced features such as Doppler and strain imaging, and user-friendly interfaces that simplify operation. This technological leap has made POCUS a more reliable and versatile diagnostic tool, attracting broader adoption across clinical settings. For instance, Butterfly Network, Inc., a digital health business, received FDA approval in January 2024 for Butterfly iQ3, a next-generation handheld point-of-care ultrasound (POCUS) system. The new gadget is the third version of the world's first single-probe, whole-body ultrasound system based on semiconductor technology. With its all-new ergonomic form, Butterfly iQ3 will process data twice as quickly for optimal picture resolution, sensitivity, and penetration. It will also have faster 3D capabilities, enabling new automated image-capturing modes like IQ Slice and IQ Fan.

The cost-effectiveness of handheld POCUS devices compared to traditional ultrasound machines is a significant factor driving the market. These portable scanners offer a more affordable alternative, particularly for smaller clinics and hospitals with limited budgets. The lower procurement cost and the ability to perform point-of-care imaging make handheld POCUS devices a financially viable solution for improving patient care. Thus, the increasing demand for POCUS in various clinical settings and technological advancements boost the handheld ultrasound scanners market growth.

On the contrary, the shortage of skilled professionals and limited battery life of portable ultrasound scanners hampers the growth of Europe handheld ultrasound scanners market.

Based on product type, the Europe handheld ultrasound scanners market is segmented into 2D handheld ultrasound scanners, 3D/4D handheld ultrasound scanners, and doppler ultrasound. The 2D handheld ultrasound scanners segment held 60.2% market share in 2023, amassing US$ 48.68 million. It is projected to garner US$ 171.89 million by 2031 to register 17.1% CAGR during 2023-2031.

In terms of application, the Europe handheld ultrasound scanners market is bifurcated into gynecology, neurology, cardiology, urology, aesthetics, musculoskeletal, veterinary, and other applications. The gynecology segment held 36.9% share of Europe handheld ultrasound scanners market in 2023, amassing US$ 29.87 million. It is anticipated to garner US$ 123.63 million by 2031 to expand at 19.4% CAGR during 2023-2031.

By end user, the Europe handheld ultrasound scanners market is segmented into hospitals and ambulatory care centers, diagnostic centers, military usage, remote areas, primary care/family medicine, medical/nurse education, veterinary clinics, and others. The hospitals and ambulatory care centers segment held 28.5% market share in 2023, amassing US$ 23.04 million. It is projected to garner US$ 91.77 million by 2031 to register 18.9% CAGR during 2023-2031.

By country, the Europe handheld ultrasound scanners market is segmented into the UK, Germany, France, Spain, Italy, Russia, Switzerland, Serbia, Romania, and the Rest of Europe. Our regional analysis states that Germany captured 25.3% share of Europe handheld ultrasound scanners market in 2023. It was assessed at US$ 20.49 million in 2023 and is likely to hit US$ 84.15 million by 2031, registering a CAGR of 19.3% during 2023-2031.

Key players operating in the Europe handheld ultrasound scanners market are GE HealthCare Technologies Inc, Siemens Healthineers AG, Koninklijke Philips NV, Sonoscanner, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Clarius Mobile Health Corp, Butterfly Network Inc, ESAOTE SPA, ASUSTek Computer Inc, and FUKUDA DENSHI, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com